Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2005 1
2006 1
2009 1
2011 1
2012 1
2013 1
2014 4
2015 1
2016 2
2017 4
2018 7
2019 2
2020 2
2021 2
2022 4
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Targeting therapeutics to endothelium: are we there yet?
Kiseleva RY, Glassman PM, Greineder CF, Hood ED, Shuvaev VV, Muzykantov VR. Kiseleva RY, et al. Among authors: hood ed. Drug Deliv Transl Res. 2018 Aug;8(4):883-902. doi: 10.1007/s13346-017-0464-6. Drug Deliv Transl Res. 2018. PMID: 29282646 Free PMC article. Review.
Nanocarriers for vascular delivery of anti-inflammatory agents.
Howard MD, Hood ED, Zern B, Shuvaev VV, Grosser T, Muzykantov VR. Howard MD, et al. Among authors: hood ed. Annu Rev Pharmacol Toxicol. 2014;54:205-26. doi: 10.1146/annurev-pharmtox-011613-140002. Annu Rev Pharmacol Toxicol. 2014. PMID: 24392694 Free PMC article. Review.
Targeted In Vivo Loading of Red Blood Cells Markedly Prolongs Nanocarrier Circulation.
Glassman PM, Villa CH, Marcos-Contreras OA, Hood ED, Walsh LR, Greineder CF, Myerson JW, Shuvaeva T, Puentes L, Brenner JS, Siegel DL, Muzykantov VR. Glassman PM, et al. Among authors: hood ed. Bioconjug Chem. 2022 Jul 20;33(7):1286-1294. doi: 10.1021/acs.bioconjchem.2c00196. Epub 2022 Jun 16. Bioconjug Chem. 2022. PMID: 35710322
Mechanisms by Which Liposomes Improve Inhaled Drug Delivery for Alveolar Diseases.
Ferguson LT, Ma X, Myerson JW, Wu J, Glassman PM, Zamora ME, Hood ED, Zaleski M, Shen M, Essien EO, Shuvaev VV, Brenner JS. Ferguson LT, et al. Among authors: hood ed. Adv Nanobiomed Res. 2023 Mar;3(3):2200106. doi: 10.1002/anbr.202200106. Epub 2023 Jan 27. Adv Nanobiomed Res. 2023. PMID: 37266328 Free PMC article.
Supramolecular arrangement of protein in nanoparticle structures predicts nanoparticle tropism for neutrophils in acute lung inflammation.
Myerson JW, Patel PN, Rubey KM, Zamora ME, Zaleski MH, Habibi N, Walsh LR, Lee YW, Luther DC, Ferguson LT, Marcos-Contreras OA, Glassman PM, Mazaleuskaya LL, Johnston I, Hood ED, Shuvaeva T, Wu J, Zhang HY, Gregory JV, Kiseleva RY, Nong J, Grosser T, Greineder CF, Mitragotri S, Worthen GS, Rotello VM, Lahann J, Muzykantov VR, Brenner JS. Myerson JW, et al. Among authors: hood ed. Nat Nanotechnol. 2022 Jan;17(1):86-97. doi: 10.1038/s41565-021-00997-y. Epub 2021 Nov 18. Nat Nanotechnol. 2022. PMID: 34795440 Free PMC article.
Molecularly Engineered Nanobodies for Tunable Pharmacokinetics and Drug Delivery.
Glassman PM, Walsh LR, Villa CH, Marcos-Contreras OA, Hood ED, Muzykantov VR, Greineder CF. Glassman PM, et al. Among authors: hood ed. Bioconjug Chem. 2020 Apr 15;31(4):1144-1155. doi: 10.1021/acs.bioconjchem.0c00003. Epub 2020 Mar 20. Bioconjug Chem. 2020. PMID: 32167754 Free PMC article.
Combating Complement's Deleterious Effects on Nanomedicine by Conjugating Complement Regulatory Proteins to Nanoparticles.
Wang Z, Hood ED, Nong J, Ding J, Marcos-Contreras OA, Glassman PM, Rubey KM, Zaleski M, Espy CL, Gullipali D, Miwa T, Muzykantov VR, Song WC, Myerson JW, Brenner JS. Wang Z, et al. Among authors: hood ed. Adv Mater. 2022 Feb;34(8):e2107070. doi: 10.1002/adma.202107070. Epub 2022 Jan 11. Adv Mater. 2022. PMID: 34910334 Free PMC article.
Biocompatible coupling of therapeutic fusion proteins to human erythrocytes.
Villa CH, Pan DC, Johnston IH, Greineder CF, Walsh LR, Hood ED, Cines DB, Poncz M, Siegel DL, Muzykantov VR. Villa CH, et al. Among authors: hood ed. Blood Adv. 2018 Feb 13;2(3):165-176. doi: 10.1182/bloodadvances.2017011734. Blood Adv. 2018. PMID: 29365311 Free PMC article.
Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers.
Ferguson LT, Hood ED, Shuvaeva T, Shuvaev VV, Basil MC, Wang Z, Nong J, Ma X, Wu J, Myerson JW, Marcos-Contreras OA, Katzen J, Carl JM, Morrisey EE, Cantu E, Villa CH, Mitragotri S, Muzykantov VR, Brenner JS. Ferguson LT, et al. Among authors: hood ed. ACS Nano. 2022 Mar 22;16(3):4666-4683. doi: 10.1021/acsnano.1c11374. Epub 2022 Mar 10. ACS Nano. 2022. PMID: 35266686 Free PMC article.
33 results